COVID-19 疫苗在多发性硬化症患者中的安全性, 免疫原性, 有效性和可接受性: 叙述性文献综述

F Capone, M Rossi, A Cruciani, F Motolese… - 中国神经再生研究 …, 2023 - sjzsyj.com.cn
larger cohort of MS patients (324 PwMS) who received the Pfizer/BioNTech BNT162b2 vaccine
… number of people who got infected by SARS-CoV-2 after vaccination. Overall, the results …

[PDF][PDF] 2021 年新冠病毒变异, 跨种传播及疫苗和药物研究热点回眸

杨婧, 荣文婉, 桓瑜, 龚玉环, 毕玉海 - 科技导报, 2022 - kjdb.org
… of the BNT162b2 mRNA COVID-19 vaccine for preventing … in the UK: A prospective,
longitudinal, cohort study[J]. Lancet … interspecies transmission risk of SARS-CoV-2 between …

[HTML][HTML] 云南地区HIV/AIDS 人群新型冠状病毒疫苗接种情况及接种意愿的调查

吕松琴, 黄山, 马礼堂, 王秀, 张洪涛, 李钦… - 昆明医科大学 …, 2024 - kyxuebao.kmmu.edu.cn
after the vaccination (19.72%). The factors affecting the … and scientific advice and guidance
from doctors and the full … vaccine are the key to complete vaccination and put an end to …

[HTML][HTML] 中国流感疫苗预防接种技术指南(2023-2024)

IV TWG, National Immunization Advisory Committee… - 中华流行病学 …, 2023 - html.rhhz.net
… the risk of interaction or co-circulation of respiratory infectious diseases … vaccination. For
adults aged ≥18 years, co-administration of inactivated SARS-CoV-2 and influenza vaccines in …

[HTML][HTML] 中国流感疫苗预防接种技术指南(2022-2023)

IV TWG, National Immunization Advisory Committee… - 中华流行病学 …, 2022 - html.rhhz.net
infectiousfrom influenza and limit the impact on the effort to prevent and control COVID-19
in China, the Technical Guidelines recommend priority vaccination of the following high-risk